Location History:
- Kenmore, NY (US) (1994)
- Durham, NC (US) (1996)
- Mebane, NC (US) (2019 - 2021)
Company Filing History:
3 out of 2,010 
1 out of 832,891 Years Active: 1994-2021
Title: The Innovative Contributions of Thomas L Ortel
Introduction
Thomas L Ortel is a notable inventor based in Mebane, NC, with a commendable portfolio of four patents. His work primarily focuses on the field of platelet function and has significant implications for antiplatelet therapy in patients. Ortel’s innovative approaches have the potential to enhance patient care by enabling better diagnosis and treatment options.
Latest Patents
Among Ortel's latest patents is a groundbreaking development in diagnostic markers for platelet function. This patent discloses biomarkers that assess platelet activity in response to antiplatelet therapy. By detecting and quantifying these biomarkers in patients, healthcare providers can determine prognosis, diagnosis, and risk identification more effectively. This innovation allows for optimal treatment decisions, identifying candidates for antiplatelet agents and enabling more precise monitoring and adjustment of therapy.
Career Highlights
Throughout his career, Thomas L Ortel has notably contributed to the medical field while working at esteemed institutions such as Duke University. His expertise in developing diagnostic tools has proven impactful in clinical settings, advancing both research and practical applications in platelet function assessment.
Collaborations
Ortel has collaborated with esteemed professionals like Geoffrey S Ginsburg and Joseph E Lucas, enhancing his research and the reach of his inventions. These collaborations reflect the interdisciplinary nature of his work, bringing together diverse expertise to push the boundaries of medical diagnostics.
Conclusion
In conclusion, Thomas L Ortel stands out as an innovative inventor whose contributions to the field of platelet function diagnostics are paving the way for improved patient care. His latest patents underscore the importance of biomarker research in clinical applications, showcasing the ongoing potential for innovation in medical technology. Through his career and collaborations, Ortel continues to make significant strides in transforming healthcare practices.